[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$wves
$wves engagements are up, but market volatility causes investor concern. Leerink and Raymond James remain optimistic about the future of $wves, despite the market conditions.
About $wves
A cryptocurrency.
Insights #
- $wves engagements is up XXXXX% from the previous week.
Engagements: XX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Week: XXX +23%
1 Month: XXX -XX%
1-Year High: XXXXX on 2025-09-03
1-Year Low: X on 2025-08-20
| Social Network | X |
|---|---|
| Engagements | XX |
Mentions: X #
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1 Month: X +100%
1-Year High: X on 2025-09-10
1-Year Low: X on 2025-06-21
| Social Network | X |
|---|---|
| Mentions | X |
Creators: X #
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $wves in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1 Month: X +100%
1-Year High: X on 2025-09-10
1-Year Low: X on 2025-06-21
Top assets mentioned In the posts about $wves in the last XX hours
Novo-Nordisk (NVO) GSK plc (GSK) GSK plc (GSK)
Top topics mentioned In the posts about $wves in the last XX hours
stocks healthcare, $nvo, gsk plc, $gsk
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Leerink $WVE's PT to $XX from $XX reit'd Outperform & said it thinks invs should take advantage of weakness to buy ahead of add'l important catalysts which they remain optimistic investors will appreciate. $GSK $ARWR $TAK $KRRO $SNY $NTLA $BEAM $LLY $NVO $VKTX $GPCR Raymond James reit'd $WVE Outperform-$14 & said We continue to view $WVE's wholly-owned gene-editing programs as more likely LT value drivers - sees WVE-007 (INHBE) in obesity (4Q 2025) as the most important near-term stock-moving catalyst with an attractive risk/ reward skew. Leerink and Raymond James said in their notes to"
X Link @Quantumup1 2025-09-03T18:17Z 3826 followers, 6444 engagements